Skip to main content

Table 1 The general characteristics of the extracted data and quality of the included studies

From: Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: a meta-analysis of 3410 gastric cancer patients

Study

Country

Study design

Group

Cases (n)

Age (mean (SD) or median)

BMI (mean (SD) or median)

TNM stage (I/II/II/IV)

OS (3-year or 5-year)

RFS (3-year or 5-year)

Relapse (n)

HLN ((mean (SD) or median)

Follow-up time (median (range) (M)

Quality

Gao Y

2018

China

R

RG

LG

163

339

60.27 ± 10.50

59.36 ± 11.08

23.77 ± 3.11

23.44 ± 3.47

0/57/106/0

0/169/170/0

76.1%

81.7%

73.0% 67.6%

44

106

30.55 ± 10.13

29.34 ± 9.76

50.5 (36–72)

good

Lee J 2015

Korea

R

RG

LG

133

267

53.6 ± 13.2

59.2 ± 11.7

23.2 ± 2.7

23.7 ± 2.8

101/15/17/0

218/32/17/0

94.7%

93.2%

NA

NA

41.2 ± 13.1

39.9 ± 13.3

75 (36–126)

good

Li Z 2018

China

R

RG

LG

125

329

55.4 ± 11.5

56.9 ± 10.5

23.7 ± 2.8

23.1 ± 3.0

24/51/50/0

37/127/165/0

78.6% 74.1%

81.2%

78.6%

21

24

29.5 ± 9.6

27.7 ± 8.7

28 (3–52)

good

Nakauchi M 2016

Japan

R

RG

LG

84

437

64

68

22.6

21.8

61/10/12/1

310/80/42/5

86.9% 88.8%

86.9%

86.3%

11

60

40

38

42.2 (1.7–78.9)

good

Obama K 2017

Japan

R

RG

LG

315

525

54.5 ± 12.6

59.3 ± 11.9

23.6 ± 3.1

23.5 ± 2.9

254/30/31/0

441/64/20/0

93.3%

91.6%

90.7%

90.5%

21

26

40.1 ± 15.4

38.6 ± 14.5

85 (60–114)

good

Pugliese R 2010

Italy

R

RG

LG

18

52

NA

NA

All (50/8/9/3)

78%

85%

NA

4

8

25 ± 4.5

31 ± 8

53 (3–112)

fair

Son T 2014

Korea

R

RG

LG

51

58

55.3 ± 12.2

58.8 ± 12.2

22.7 ± 2.9

23.2 ± 3.3

35/8/8/0

43/10/5/0

89.5%

91.1%

90.2%a 91.2%a

3

3

47.2,

42.8

70 (24–112)

good

Zhou J 2014

China

R

RG

LG

120

394

54.7

55.6

21.6 ± 2.8

21.7 ± 2.6

29/36/55/0

115/98/181/0

67.8%

69.9%

NA

5

28

34.6 ± 10.9

32.7 ± 11.2

17 (3–41)

good

  1. BMI body mass index, HLN harvested lymph nodes, M months, NA not available, OS overall survival, R retrospective, RFS relapse-free survival, SD standard deviation. aDisease-free survival